Yong Ben
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-08-11–present
-
Current
2024-01-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | M.D., M.B.A.^^ Chief Medical and Development Officer | $525,300 | $3,227,364 |
| 2024 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | M.D., M.B.A.^^ Chief Medical and Development Officer | $170,346 | $1,455,587 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.